Lu C - Search Results

1

The efficacy of probiotics in patients with severe COVID-19.

Wang H, Wang Y, Lu C, Qiu L, Song X, Jia H, Cui D, Zhang G. Wang H, et al. Among authors: lu c. Ann Palliat Med. 2021 Dec;10(12):12374-12380. doi: 10.21037/apm-21-3373. Ann Palliat Med. 2021. PMID: 35016484 Free article.

2

Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1.

Cheng R, Lu C, Zhang G, Zhang G, Zhao G. Cheng R, et al. Among authors: lu c. Oncol Rep. 2017 Apr;37(4):2129-2136. doi: 10.3892/or.2017.5505. Epub 2017 Mar 13. Oncol Rep. 2017. Retraction in: Oncol Rep. 2023 Feb;49(2):24. doi: 10.3892/or.2022.8461 PMID: 28350100 Retracted.

3

Overexpression of miR-519d in lung adenocarcinoma inhibits cell proliferation and invasion via the association of eIF4H.

Bai Y, Lu C, Zhang G, Hou Y, Guo Y, Zhou H, Ma X, Zhao G. Bai Y, et al. Among authors: lu c. Tumour Biol. 2017 Mar;39(3):1010428317694566. doi: 10.1177/1010428317694566. Tumour Biol. 2017. PMID: 28351305 Free article.

4

MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2.

Zhang G, Zheng H, Zhang G, Cheng R, Lu C, Guo Y, Zhao G. Zhang G, et al. Among authors: lu c. Cancer Cell Int. 2017 Apr 17;17:46. doi: 10.1186/s12935-017-0415-9. eCollection 2017. Cancer Cell Int. 2017. PMID: 28428733 Free PMC article.

5

Long Non-Coding RNA XLOC_008466 Functions as an Oncogene in Human Non-Small Cell Lung Cancer by Targeting miR-874.

Yang R, Li P, Zhang G, Lu C, Wang H, Zhao G. Yang R, et al. Among authors: lu c. Cell Physiol Biochem. 2017;42(1):126-136. doi: 10.1159/000477121. Epub 2017 May 12. Cell Physiol Biochem. 2017. Retraction in: Cell Physiol Biochem. 2023 Dec 31;57(6):541. doi: 10.33594/000000676 PMID: 28501870 Free article. Retracted.

6

miR-125a-5p upregulation suppresses the proliferation and induces the cell apoptosis of lung adenocarcinoma by targeting NEDD9.

Zheng H, Wu J, Shi J, Lu C, Wang Y, Sun Q, Zhang G, Zhao G. Zheng H, et al. Among authors: lu c. Oncol Rep. 2017 Sep;38(3):1790-1796. doi: 10.3892/or.2017.5812. Epub 2017 Jul 13. Oncol Rep. 2017. Retraction in: Oncol Rep. 2023 Feb;49(2):29. doi: 10.3892/or.2022.8466 PMID: 28714018 Retracted.

7

Baicalein inhibits cell growth and increases cisplatin sensitivity of A549 and H460 cells via miR-424-3p and targeting PTEN/PI3K/Akt pathway.

Lu C, Wang H, Chen S, Yang R, Li H, Zhang G. Lu C, et al. J Cell Mol Med. 2018 Apr;22(4):2478-2487. doi: 10.1111/jcmm.13556. Epub 2018 Feb 1. J Cell Mol Med. 2018. PMID: 29392841 Free PMC article.

8

MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer.

Wang H, Wang L, Zhang G, Lu C, Chu H, Yang R, Zhao G. Wang H, et al. Among authors: lu c. Oncotarget. 2017 Dec 14;9(7):7501-7512. doi: 10.18632/oncotarget.23483. eCollection 2018 Jan 26. Oncotarget. 2017. PMID: 29484127 Free PMC article.

9

Aberrant expression of hsa_circ_0025036 in lung adenocarcinoma and its potential roles in regulating cell proliferation and apoptosis.

Wu S, Li H, Lu C, Zhang F, Wang H, Lu X, Zhang G. Wu S, et al. Among authors: lu x, lu c. Biol Chem. 2018 Nov 27;399(12):1457-1467. doi: 10.1515/hsz-2018-0303. Biol Chem. 2018. PMID: 30138108

10

Piperlongumine inhibits the growth of non-small cell lung cancer cells via the miR-34b-3p/TGFBR1 pathway.

Lu X, Xu C, Xu Z, Lu C, Yang R, Zhang F, Zhang G. Lu X, et al. Among authors: lu c. BMC Complement Med Ther. 2021 Jan 7;21(1):15. doi: 10.1186/s12906-020-03123-y. BMC Complement Med Ther. 2021. PMID: 33413277 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,821 results

Search Page

Filters